학술논문
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
Document Type
Article
Author
Zhang, Q.; Han, L.; Jia, Y.; Ruvolo, V.R.; Ma, H.; Weng, C.C.; Ramage, C.L.; Baran, N.; Shi, C.; Cai, T.; Battula, V.L.; DiNardo, C.D.; Andreeff, M.; Konopleva, M.; Riley-Gillis, B.; Grosskurth, S.E.; Vijay, P.; Ghosh, S.; Lu, C.; Leverson, J.; Popovic, R.; Mi, Y.; Lodi, A.; Sweeney, S.R.; Tiziani, S.; Zhang, H.; Kurtz, S.; Tyner, J.W.; Ganesan, S.; Padua, R.A.; Pan, R.; Ryan, J.A.; Letai, A.; Konoplev, S.N.; Schimmer, A.; Bueso-Ramos, C.E.; Jitkova, Y.; Dunner, K.; Ma, W.; Wang, J.; Davis, R.E.
Source
In: Signal Transduction and Targeted Therapy . (Signal Transduction and Targeted Therapy, December 2022, 7(1))
Subject
Language
English
ISSN
20593635
20959907
20959907